Program aims to restore normal tissue function and eliminate lengthy transplant wait times
The Advanced Research Projects Agency for Health (ARPA-H) has posted a funding opportunity in support of the Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) Program.
PRINT intends to use state-of-the-art bioprinting technology and a regenerative medicine approach to 3D print personalized, on demand organs that will not require immunosuppressive drugs.
Currently, many individuals need to wait multiple years for a suitable organ or may never receive one. In the U.S., there are 120,000 people on wait lists and only 45,000 transplants performed each year, resulting in an ongoing organ shortage and deaths among those waiting for an organ. Transplanted organs typically last 15-23 years, and all require immunosuppressive drugs for life, which can come with both significant cost and health challenges.
ARPA-H will host a Proposer's Day on May 07, 2024. The event will allow for both in-person and virtual participation and is intended to facilitate teaming and foster a greater understanding of the PRINT Program. The closing date for registration is April 30, 2024, 1:00 PM ET.
In-person attendance is first-come, first-served or when capacity is reached. After reviewing the Proposers' Day information, interested parties are encouraged to register:
Solution Summary Due Date and Time: May 28, 2024, 9:00 AM ET
Proposals will be by invitation only. Proposal Due Date and Time: July 8, 2024, 5:00 PM EDT.
Learn more at arpa-h.gov/research-and-funding/programs/print
View the government contract opportunity information at sam.gov.
For more information about ARPA-H, visit arpa-h.gov.
Read the announcement at arpa-h.gov/news-and-events.
